Is the Hp 2-2 diabetic mouse model a good model to study diabetic nephropathy?

Zimmet, 2001, Global and social implications of the diabetes epidemic, Nature, 414, 782, 10.1038/414782a Parving, 1996, Genetics of diabetic nephropathy, J Am Soc Nephrol, 7, 2509, 10.1681/ASN.V7122509 Chowdhury, 1999, Genetic determinants of diabetic nephropathy, Clin Sci, 96, 221, 10.1042/CS19980331 Levy, 2010, Haptoglobin: basic and clinical aspects, Antioxid Redox Signal, 12, 293, 10.1089/ars.2009.2793 Goldenstein, 2012, Haptoglobin genotype and its role in determining heme-iron mediated vascular disease, Pharmacol Res, 66, 1, 10.1016/j.phrs.2012.02.011 Costacou, 2012, Haptoglobin genotype and its role in diabetic cardiovascular disease, J Cardiovasc Transl Res, 5, 423, 10.1007/s12265-012-9361-z Kalet-Litman, 2010, The haptoglobin 2-2 genotype is associated with increased redox active hemoglobin derived iron in the atherosclerotic plaque, Atherosclerosis, 209, 28, 10.1016/j.atherosclerosis.2009.09.002 Fioretto, 2010, Diabetic nephropathy-challenges in pathologic classification, Nat Rev Nephrol, 6, 508, 10.1038/nrneph.2010.96 Brosius, 2009, Mouse models of diabetic nephropathy, J Am Soc Nephrol, 20, 2503, 10.1681/ASN.2009070721 Breyer, 2005, Mouse models of diabetic nephropathy, J Am Soc Nephrol, 16, 27, 10.1681/ASN.2004080648 Fujita, 2012, A novel diabetes mellitus mouse model, MAFK-overexpressing hybride transgenic mice, developed severe diabetic nephropathy and improved with TCV-111 (Candesartan Cilexetil) treatment, Exp Anim, 61, 49, 10.1538/expanim.61.49 Chang, 2012, Diabetic kidney disease in FVB/NJ Akita mice: temporal pattern of kidney injury and urinary nephrin excretion, PLoS ONE, 7, 4 Blum, 2008, Pharmacogenomic application of the haptoglobin genotype in the prevention of diabetic cardiovascular disease, Pharmacogenomics, 9, 989, 10.2217/14622416.9.8.989 Asleh, 2005, In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease, Vasc Health Risk Manag, 1, 19, 10.2147/vhrm.1.1.19.58930 Nakhoul, 2009, Pharmacogenomic effect of vitamin E on kidney structure and function in transgenic mice with the haptoglobin 2-2 genotype and diabetes mellitus, Am J Physiol Renal Physiol, 296, F830, 10.1152/ajprenal.90655.2008 Miller-Lotan, 2005, Increased renal hypertrophy in diabetic mice genetically modified at the haptoglobin locus, Diabetes Metab Res Rev, 21, 332, 10.1002/dmrr.556 Asleh, 2012, Poor lysosomal membrane integrity in proximal tubule cells of haptoglobin 2-2 genotype mice with diabetes mellitus, Free Radic Biol Med, 53, 779, 10.1016/j.freeradbiomed.2012.06.015 Miller-Lotan, 2007, Retinal capillary basement membrane thickness in diabetic mice genetically modified at the haptoglobin locus, Diabetes Metab Res Rev, 23, 152, 10.1002/dmrr.654 Nakhoul, 2007, Hypothesis—haptoglobin genotype and diabetic nephropathy, Nat Clin Pract Nephrol, 3, 339, 10.1038/ncpneph0467 Strauss, 2008, Regulation of CD163 associated casein kinase II activity is haptoglobin genotype dependent, Mol Cell Biochem, 317, 131, 10.1007/s11010-008-9840-3 Miller-Lotan, 2005, Increased renal hypertrophy in diabetic mice genetically modified at the haptoglobin locus, Diabetes Metab Res Rev, 21, 332, 10.1002/dmrr.556 Behzad, 2003, Atubular glomeruli and glomerulotubular junction abnormalities in diabetic nephropathy, J Am Soc Nephrol, 14, 908, 10.1097/01.ASN.0000057854.32413.81 Vardi, 2012, Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus – natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literature, Eur J Intern Med, 23, 628, 10.1016/j.ejim.2012.04.009 Blum, 2010, The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes, Atherosclerosis, 211, 25, 10.1016/j.atherosclerosis.2010.02.018 Nankivell, 1994, Lysosomal iron accumulation in diabetic nephropathy, Ren Fail, 16, 367, 10.3109/08860229409044877 Purushothaman, 2012, Increased expression of oxidation-specific epitopes and apoptosis are associated with haptoglobin genotype: possible implications for plaque progression in human atherosclerosis, J Am Coll Cardiol, 60, 112, 10.1016/j.jacc.2012.04.011 Simpson, 2011, Haptoglobin genotype predicts development of coronary artery calcification in a prospective cohort of patients with type 1 diabetes, Cardiovasc Diabetol, 10, 99, 10.1186/1475-2840-10-99 Moreno, 2008, Haptoglobin genotype is a major determinant of the amount of iron in the human atherosclerotic plaque, J Am Coll Cardiol, 52, 1049, 10.1016/j.jacc.2008.06.029 Wang, 2012, Vitamin D receptor signaling in podocytes protects against diabetic nephropathy, J Am Soc Nephrol, 23, 1977, 10.1681/ASN.2012040383 Nakhoul, 2001, Haptoglobin phenotype and diabetic nephropathy, Diabetologia, 44, 602, 10.1007/s001250051666 Sammour, 2010, Haptoglobin phenotype in women with preeclampsia endocrine, 38, 303